Lentinan ameliorates burn sepsis by attenuating CD4+ CD25+ Tregs

Burns. 2016 Nov;42(7):1513-1521. doi: 10.1016/j.burns.2016.04.003. Epub 2016 May 3.

Abstract

Aim: The aim of our study was to investigate the effect of lentinan on regulatory T cells (Tregs) in sepsis, especially on the generation of interleukin (IL)-10 via regulation of Erk-FoxO1 signaling.

Methods: BalB/c mice were randomized into five groups: sham group, the group with burns plus Pseudomonas aeruginosa infection, and the groups with burns plus P. aeruginosa infection administered 40, 100, and 250mg/kg of lentinan. The mice were sacrificed on postburn days 0, 1, 2, 3, and 4, respectively, with eight animals per group at each time point. The peripheral blood CD4+ CD25+ Tregs and CD4+ T cells were isolated using magnetic microbeads. The phenotypes were analyzed by flow cytometry. The cytokine levels were determined with enzyme-linked immunosorbent assay (ELISA). Signal transduction was studied by Western blot, quantitative polymerase chain reaction (qPCR), and luciferase assay.

Results: The IL-10-producing capacity of CD4+ CD25+ Tregs was significantly enhanced in the group with burns plus P. aeruginosa infection, compared with the sham group. Administration of lentinan significantly decreased IL-10 production and FoxP3 expression of CD4+ CD25+ Tregs. The proliferative activities of CD4+ T cells, however, were restored. Lentinan decreased lipopolysaccharide (LPS)-induced IL-10 production in the Tregs isolated from burned mice. In addition, lentinan attenuated LPS-stimulated Erk-FoxO1 activation.

Conclusions: Lentinan may improve the outcome of postburn sepsis by suppressing LPS-triggered Erk-FoxO1 activation. Consequently, the hyperfunction of CD4+ CD25+ Tregs is inhibited, leading to a shift in the inflammatory status from Th2 to Th1 in postburn sepsis.

Keywords: Burn; CD4(+) CD25(+) Tregs; Lentinan; P. aeruginosa; Sepsis.

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • Blotting, Western
  • Burns / immunology*
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Proliferation / drug effects
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Forkhead Box Protein O1 / drug effects
  • Forkhead Box Protein O1 / genetics
  • Forkhead Box Protein O1 / immunology
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology
  • Interleukin-2 Receptor alpha Subunit / immunology
  • Lentinan / pharmacology*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / genetics
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Pseudomonas Infections / immunology*
  • Pseudomonas aeruginosa
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sepsis / immunology*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • T-Lymphocytes, Regulatory / drug effects*
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Adjuvants, Immunologic
  • Forkhead Box Protein O1
  • Foxo1 protein, mouse
  • IL10 protein, mouse
  • Interleukin-2 Receptor alpha Subunit
  • Interleukin-10
  • Lentinan